Good MorningInvestors and traders got a double-shot of good news from Fed chief Jerome Powell’s second day of testimony on Capitol Hill. In his comments, Mr. Powell both affirmed the need for more stimulus while also indicating the economic recovery is well underway. The pandemic is still a concern as are high levels of joblessness but the general outlook is positive. Add to that a lack of concern for the possibility of rising inflation and it is no surprise the broad market S&P 500 gained 1.0%.
Technically speaking, Wednesday’s gain in the market is a bullish signal. The market made a solid move higher confirming support at a key technical level, the 30-day moving average. The 30-day moving average is a gauge of near-term sentiment and an indication of which direction short-term traders are placing their bets. With the moving average trending higher and support at the average confirmed new all-time highs for the S&P 500 index are all but assured.
Featured: The 7 Stocks Quietly Gaining Attention Right Now (Ad) 
|
Industrials | |
Plug Power (NASDAQ:PLUG) is among the electric vehicle stocks that have faced much of the recent market backlash surrounding technology valuations. With the EV space unplugged at the moment, some companies may be finding new homes at more palatable prices while others are simply recharging for the... Read the Full Story |
|
|
Healthcare | |
Now that we’ve seen some volatility in February, it might be time to take a long hard look at your portfolio holdings. If you were feeling very uncomfortable during the recent market weakness, you might be overexposed to things like growth stocks or simply haven’t accurately defined yo... Read the Full Story |
|
Markets | | Square Rides Bitcoin To Triple-Digit Growth
Square (NASDAQ:SQ) is an up-and-coming fintech that is benefiting greatly from the shift to eCommerce spurred by the pandemic, and from renewed interest in cryptocurrency. The company, already growing at a significant clip, saw its revenue growth accelera... Read the Full Story |
|
From Our Partners | | Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade.
This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan. | | Claim your free options guide and start building real trading knowledge |
|
Healthcare | |
Medical services got a fundamental shift when Teladoc Health (NYSE:TDOC) came on the scene. With a pandemic in full swing, and medical professionals at least a little leery about being in the same room with patients, Teladoc was a godsend. Its primary stock in trade—a system that allowed fo... Read the Full Story |
|
Technology | | Having watched shares drop as much as 12% from all-time highs in recent weeks, investors of Nvidia (NASDAQ: NVDA) got a big boost last night when the chipmaker released their Q4 earnings. GAAP EPS came in at $2.31, a full $0.33, or 15%, higher than what analysts were expecting. Topline revenue was a... Read the Full Story |
|
From Our Partners | | More than 25 candidates were screened for share price between $1 and $5, market cap above $100 million, daily volume over 500,000 shares, and over $10 million in trailing revenue.
Only five stocks cleared every filter, spanning five different sectors. Two are profitable today, and one pays a substantial dividend.
The report also flags what could go wrong with each pick, including dilution and convertible debt. | | See the five stocks that survived this strict revenue screen |
|
Technology | | Salesforce (NYSE: CRM) is slated to release its Q4 earnings today after the bell; the cloud-based software company is expected to see revenue growth of 17.1% and EPS growth of 13.8%. But Salesforce has a solid track record of beating expectations, so expect those numbers to be even better.
So, case... Read the Full Story |
|
Consumer Discretionary | |
There’s something to be said about adding an iconic brand name company like McDonald’s (NYSE:MCD) to your long-term investment portfolio. It’s one of those businesses that offer an instantly recognizable and familiar experience for its customers, regardless of which one of the 38... Read the Full Story |
|
Markets | | Canada-based uranium exploration and development company Denison Mines (NYSE: DNN) stock rapidly spiked in recent months on the rising demand for uranium. The Biden administration's clean energy agenda, U.S. uranium reserves plan, combined with the global decarbonization and clean energy initiative ... Read the Full Story |
|
Healthcare | |
Penny stock investors have made a nice profit on AIM ImmunoTech (NYSEAMERICAN:AIM) in 2020. In the last 12 months, AIM stock is up 115%. Going back just a little further to the start of 2020, the stock has climbed over 300%. And at various times in 2020, shares of AIM ImmunoTech were trading much ... Read the Full Story |
|
Consumer Discretionary | | Growth To Slow For LGI Homes
LGI Homes, Inc (NASDAQ:LGIH) is one of the smaller home builders but is no less important to the industry. The company has been quietly growing by double digits for the last several years and is on track to continue growing in 2021. The problem for the market right now ... Read the Full Story |
|
The Early Bird Stock Of The Day Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. | | View Today's Stock Pick |
|
